Company profile: Alafair Biosciences
1.1 - Company Overview
Company description
- Provider of biomaterials and biomedical devices to enhance internal wound healing, including VersaWrap, a plant-based, bioresorbable hydrogel implant designed to provide a gliding surface for tendons, ligaments, skeletal muscles, and peripheral nerves, reducing friction and preventing postoperative tethering.
Products and services
- VersaWrap: A plant-based hydrogel implant that creates a gliding interface for tendons, ligaments, skeletal muscles, and peripheral nerves, bioresorbing to reduce friction and prevent postoperative tethering
- Biomaterials Commercialization: An internal wound healing-focused service that commercializes biomaterials to enhance tissue repair by reducing friction and postoperative tethering across tendons, ligaments, skeletal muscles, and peripheral nerves
- Biomedical Devices Commercialization: A wound-healing-centric program that commercializes biomedical devices aimed at improving internal tissue gliding and minimizing postoperative tethering for musculoskeletal and peripheral nerve applications
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Alafair Biosciences
Lamellar
HQ: United Kingdom
Website
- Description: Provider of novel healthcare products based on mimicry or modification of the lamellar body secretory system, leveraging Lamellasomes™ technology and associated intellectual property.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lamellar company profile →
Lotus Tissue Repair
HQ: United States
Website
- Description: Provider of proprietary recombinant human collagen Type VII (rC7) technology for accelerating chronic wound healing in dermatologic conditions, including diabetic foot ulcers, venous stasis ulcers and similar conditions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lotus Tissue Repair company profile →
MiMedx
HQ: United States
Website
- Description: Provider of wound care and therapeutic biologics, offering human amniotic membrane and umbilical cord allografts for wound care (including diabetic foot ulcers and venous leg ulcers) and surgical applications. Products include EPIFIX, EPICORD, AMNIOFIX, AMNIOCORD, AMNIOBURN for burn care, and AXIOFILL, a biocompatible acellular human placental extracellular matrix to replace or supplement damaged or inadequate integumental tissue.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MiMedx company profile →
BioD Logics
HQ: United States
Website
- Description: Provider of novel biologic products derived from placental tissues, engaged in the development and commercialization of biologics and focused on research into the regenerative potential of amnion and other placental tissues; a vertically integrated biotechnology company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioD Logics company profile →
PolarityTE
HQ: United States
Website
- Description: Provider of SkinTE, an investigational product for complex chronic and acute wound treatment that uses a patient's own tissue to regenerate functional skin, and a clinical development program advancing SkinTE through clinical trials to obtain regulatory approval.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PolarityTE company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Alafair Biosciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Alafair Biosciences
2.2 - Growth funds investing in similar companies to Alafair Biosciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Alafair Biosciences
4.2 - Public trading comparable groups for Alafair Biosciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →